Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

World market for personalized medicine diagnostics


Published on

Published in: Business, Technology
  • Be the first to comment

  • Be the first to like this

World market for personalized medicine diagnostics

  1. 1. World Market for Personalized Medicine Diagnostics (Biomarkers,Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)A special focus of the report is the bustle of activity with collaborations between IVD andpharmaceutical companies, as well as IVD companies and CLIA labs. This report profilesscores of such companies operating in this market and estimates and forecasts markets(where there are products on the market) for personalized medicine technologies in thefollowing categories:  Cardiac Markers, immunoassays  Cardiac Risk Markers  Cardiac markers, molecular  Coagulation, routine  Coagulation, molecular  Cancer, Tumor Markers  Cancer, Molecular  Cancer, Tissue-based  Psychiatric Disorders  Diabetes, BGM  Diabetes, HbA1c  Microbiology, ID/AST  Infectious Diseases, Viral Load (HIV, HCV, HBV)  Infectious Diseases, other  Blood Bank Molecular  Transplant Tissue Typing  Lab Developed TestsRequest a Sample for or Inquire before buying the report Personalized MedicineDiagnostics MarketIn this market research report, Kalorama Information defines the current opportunity and arealistic future potential for personalized medicine in clinical testing. In addition to analysisof tests currently on the market and in development, the report profiles key competitorsand discusses trends that are important for understanding this much-discussed growth areaof the diagnostic industry.Developments that are linked in the press to personalized medicine are many, and can attimes be confusing. But there are several discovered biomarkers that are important indiagnostic markets.Biomarkers discussed in the report include:  Cytochrome P450 and Drug Metabolism  Estrogen Receptor and Progesterone  Receptor Status for Breast Cancer  HER2 Overexpression and Herceptin and Tykerb  Epidermal Growth Factor Receptor (EGFR)  KRAS Mutations and Anti-EGFR Therapy for Colorectal Cancer
  2. 2.  BRAF Mutations and Cancer Therapy  UGT1A1 Genetic Variants  5-Flurouracil Therapy  PIK3CA Genetic Variation  KIF6 Genetic Variation  ALK Genetic VariationMajor points covered in Table of Contents of this report include:  CHAPTER ONE: EXECUTIVE SUMMARY  CHAPTER TWO: INTRODUCTION  CHAPTER THREE: STRATEGIC ISSUES: THE “COMMERCIALIZATION CONDUNDRUM”  CHAPTER FOUR: DISEASE TARGETS  CHAPTER FIVE: DIAGNOSTIC TECHNOLOGIES  CHAPTER SIX: MARKET ANALYSIS  CHAPTER SEVEN: CONCLUSIONS AND STRATEGIC IMPLICATIONS  CHAPTER EIGHT: COMPANY PROFILES  List of TablesExplore Reports related to Biotechnology @ Details:Published: March 2012No. of Pages: 430Price: Single User License – US$3795 Corporate User License – US$7590Contact:Priyank Tiwari7557 Rambler road,Suite 727, Dallas, TX 75231Tel: +1-888-391-5441sales@reportsandreports.comVisit our Market Research Blog @ With Us: